We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+4.98%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$130B
AUM Growth
+$12.3B
Cap. Flow
+$1.54B
Cap. Flow %
1.18%
Top 10 Hldgs %
17.24%
Holding
8,628
New
1,223
Increased
3,315
Reduced
2,707
Closed
1,164

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$548M
2
MU icon
Micron Technology
MU
+$461M
3
C icon
Citigroup
C
+$334M
4
AVGO icon
Broadcom
AVGO
+$319M
5
ABBV icon
AbbVie
ABBV
+$267M

Sector Composition

Rank Sector Weight
1 Technology 6.99%
2 Financials 5.48%
3 Industrials 4.89%
4 Consumer Discretionary 4.88%
5 Healthcare 4.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ONCS
7151
DELISTED
OncoSec Medical Incorporated
ONCS
$27K ﹤0.01%
126
+57
+83% +$12.7K
ARLZ
7152
CALL
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
$27K ﹤0.01%
11,700
+400
+4% +$535
CPRX
7153
CALL
DELISTED
Catalyst Pharmaceutical
CPRX
$26K ﹤0.01%
10,500
-2,000
-16% -$5.49K
CPRX
7154
DELISTED
Catalyst Pharmaceutical
CPRX
$26K ﹤0.01%
10,137
-650
-6% -$1.78K
GEVO icon
7155
Gevo
GEVO
$351M
$26K ﹤0.01%
2,094
-3,612
-63% -$44.5K
TURN
7156
DELISTED
180 Degree Capital
TURN
$26K ﹤0.01%
+5,041
New +$24.6K
AXU
7157
DELISTED
Alexco Resource Corp
AXU
$26K ﹤0.01%
17,927
-17,312
-49% -$25.2K
IDSA
7158
DELISTED
Industrial Services of America
IDSA
$26K ﹤0.01%
+15,687
New +$26.2K
OREX
7159
CALL
DELISTED
Orexigen Therapeutics, Inc.
OREX
$26K ﹤0.01%
+12,300
New +$30K
FTEK icon
7160
Fuel Tech
FTEK
$42.8M
$25K ﹤0.01%
24,206
+7,448
+44% +$6.59K
GTE icon
7161
CALL
Gran Tierra Energy
GTE
$335M
$25K ﹤0.01%
+1,080
New +$23.7K
MUX icon
7162
CALL
McEwen Inc
MUX
$1.12B
$25K ﹤0.01%
+1,270
New +$31.1K
THM
7163
International Tower Hill Mines
THM
$552M
$25K ﹤0.01%
46,055
-16,434
-26% -$8.9K
CRTN
7164
DELISTED
Cartesian, Inc.
CRTN
$25K ﹤0.01%
+39,103
New +$25.4K
ENFY
7165
PUT
DELISTED
Enlightify Inc
ENFY
$24K ﹤0.01%
+1,658
New +$24.8K
CMLS
7166
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
$24K ﹤0.01%
75,092
-43,227
-37% -$17.6K
NOG icon
7167
Northern Oil and Gas
NOG
$2.21B
$23K ﹤0.01%
2,604
-156
-6% -$1.59K
RAVE icon
7168
RAVE Restaurant Group
RAVE
$44.5M
$23K ﹤0.01%
12,840
-4,133
-24% -$7.37K
WRN
7169
Western Copper and Gold
WRN
$526M
$23K ﹤0.01%
+19,807
New +$23.4K
SEEL
7170
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
0
ATHX
7171
PUT
DELISTED
Athersys, Inc. Common Stock
ATHX
$23K ﹤0.01%
+444
New +$20K
EVEP
7172
DELISTED
EV Energy Partners, L.P.
EVEP
$23K ﹤0.01%
+36,317
New +$19.2K
LUNA
7173
DELISTED
Luna Innovations Incorporated
LUNA
$23K ﹤0.01%
13,761
-2,813
-17% -$4.11K
ACHV icon
7174
Achieve Life Sciences
ACHV
$672M
$22K ﹤0.01%
55
+27
+96% +$19.4K
EYPT icon
7175
EyePoint Inc
EYPT
$1.11B
$22K ﹤0.01%
1,807
-1,033
-36% -$13.2K

Similar funds

Citadel Advisors's Q3 2017 Portfolio in Review

As of Q3 2017, Citadel Advisors held 8,628 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Citadel Advisors's Q3 2017 filing shows 1,223 new, 3,315 increased, 2,707 reduced and 1,164 closed positions. Its largest new stake was Goldman Sachs: 2,394,331 shares worth $568M. The largest sale was Visa, an estimated $548M.

By sector, the portfolio is most concentrated in Technology at 7% of assets, down from 7.1% a quarter earlier, followed by Financials and Industrials.

  • Citadel Advisors's largest Q3 2017 buy was Goldman Sachs: 2,394,331 shares worth $568M.
  • Citadel Advisors added most to Citizens Financial Group in Q3 2017, an estimated $304M increase.
  • Citadel Advisors's biggest Q3 2017 reduction was Visa, cutting an estimated $548M.
  • Citadel Advisors fully exited Citigroup in Q3 2017, selling an estimated $334M.
  • Citadel Advisors's ten largest holdings make up 17% of its $130B portfolio in Q3 2017.
  • Citadel Advisors opened 1,223 new positions and closed 1,164 in Q3 2017.
  • Citadel Advisors's portfolio value rose 10% quarter-over-quarter to $130B.

Based on Citadel Advisors's 13F filing for Q3 2017, filed 9 Nov 2017.